Skip to main content

Nantahala Capital Management, LLC

13F filer · CIK 0001472322
Reported Aug 19, 2026
Net buyer this quarter
13F portfolio value$6.02BU.S. long equity reported on 13F
Positions13120 new · 18 closed
Net flow last quarter+$1.44BBuys minus sells
Top 10 positions weight15.1%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 19, 2026131 positions
TBBKBancorp, Inc.$155M2.58%6.04%+79.6%Q2 2014
BVSBioventus Inc.$113M1.88%Not reported+96.0%Q3 2022
HGVHilton Grand Vacations Inc.$108M1.80%2.65%+36.5%Q4 2022
SVRASavara Inc$86M1.43%6.79%+90.0%Q3 2023
ETONEton Pharmaceuticals, Inc.$85.1M1.41%8.31%+100.0%Q2 2024
AMRXAmneal Pharmaceuticals, Inc.$78.5M1.30%1.42%+59.5%Q1 2023
EOLSEvolus, Inc.$77.8M1.29%16.97%+75.7%Q3 2023
AVTXAvalo Therapeutics, Inc.$68.8M1.14%7.04%+201.6%Q3 2021
LBRXLB Pharmaceuticals Inc$68.3M1.14%7.34%+100.0%Q3 2025
AVRAnteris Technologies Global Corp.$66.7M1.11%6.95%+22.3%Q4 2024
ABEOAbeona Therapeutics Inc.$63.5M1.05%17.95%+104.9%Q4 2022
PTONPeloton Interactive, Inc.$60.4M1.00%Not reported-14.9%Q1 2020
ESTAEstablishment Labs Holdings Inc.$57.6M0.96%2.25%-19.4%Q3 2018
XTNTXtant Medical Holdings, Inc.$57.6M0.96%97.52%+100.0%Q3 2023
JACKJack in the Box Inc$54.7M0.91%18.13%+124.1%Q2 2025
GOGOGogo Inc.$53.9M0.90%12.84%+95.9%Q3 2024
IMAXImax Corp$52.5M0.87%2.40%+155.3%Q4 2020
ZVRAZevra Therapeutics, Inc.$51.6M0.86%6.06%+42.6%Q3 2023
TITNTitan Machinery Inc.$47.9M0.80%9.73%+80.6%Q3 2024
RMRRMR Group Inc.$47.1M0.78%15.31%+100.0%Q4 2020
FOSLFossil Group, Inc.$45.6M0.76%18.63%+103.7%Q2 2023
FOXFFox Factory Holding Corp$44.4M0.74%6.25%+76.1%Q4 2024
MLYSMineralys Therapeutics, Inc.$44.3M0.74%1.86%+83.3%Q1 2024
RDNWRideNow Group, Inc.$43.6M0.72%298.67%+100.0%Q2 2022
QUREuniQure N.V.$42M0.70%1.31%+284.4%Q4 2016
AURAAura Biosciences, Inc.$41.9M0.70%5.70%+178.7%Q4 2021
AGMBAgomab Therapeutics NV$40.7M0.68%9.18%+161.4%Q1 2026
FULCFulcrum Therapeutics, Inc.$40.1M0.67%14.35%+259.0%Q4 2022
BNTCBenitec Biopharma Inc.$39.8M0.66%8.65%+107.0%Q2 2024
ADMAAdma Biologics, Inc.$39.5M0.66%2.09%NewQ2 2026
CWHCamping World Holdings, Inc.$38.9M0.65%Not reported+56.5%Q4 2025
BCRXBiocryst Pharmaceuticals Inc$38M0.63%1.49%+91.3%Q4 2025
MDXGMimedx Group, Inc.$36.7M0.61%6.54%+180.7%Q4 2022
ABVXAbivax S.A.$35.6M0.59%0.34%+94.9%Q4 2023
USNAUsana Health Sciences Inc$34.6M0.57%8.78%+100.0%Q4 2025
GLUEMonte Rosa Therapeutics, Inc.$31.6M0.52%1.53%+100.0%Q4 2025
TNGXTango Therapeutics, Inc.$31.3M0.52%0.59%-19.9%Q3 2021
GERNGeron Corp$31.3M0.52%3.81%+117.8%Q3 2025
VORVor Biopharma Inc.$31.1M0.52%3.10%NewQ2 2026
KROSKeros Therapeutics, Inc.$30.2M0.50%14.23%+107.4%Q2 2020
SLNSilence Therapeutics plc$29.6M0.49%1.90%+25.5%Q1 2024
APYXApyx Medical Corp$29.4M0.49%15.53%+90.1%Q4 2024
JCAPJefferson Capital, Inc. / DE$29.2M0.49%2.61%+100.0%Q2 2025
HLFHerbalife Ltd.$29.2M0.48%2.12%+63.9%Q1 2025
PLNTPlanet Fitness, Inc.$29.1M0.48%558000.00%Not reportedQ1 2020
VSTMVerastem, Inc.$27.4M0.46%7.92%+100.0%Q2 2024
DSGRDistribution Solutions Group, Inc.$27.1M0.45%2.14%+100.0%Q2 2025
RYAMRayonier Advanced Materials Inc.$26.7M0.44%5.02%+112.2%Q1 2016
HLXCHelix Acquisition Corp. III$26.6M0.44%Not reported+100.0%Q1 2026
ADCTADC Therapeutics SA$26.4M0.44%19.34%+340.4%Q4 2022
Q1 2026Reported May 15, 2026129 positions
TBBKBancorp, Inc.$74.2M2.73%3.30%+28.8%Q2 2014
HGVHilton Grand Vacations Inc.$59.2M2.18%1.88%-3.1%Q4 2022
SLNOSoleno Therapeutics Inc$58.4M2.15%3.37%+32.7%Q4 2019
BVSBioventus Inc.$55.9M2.06%Not reported+1.2%Q3 2022
PTONPeloton Interactive, Inc.$51.5M1.90%Not reported+102.3%Q1 2020
ESTAEstablishment Labs Holdings Inc.$47.3M1.74%2.83%-15.7%Q3 2018
SVRASavara Inc$40.1M1.48%3.58%Not reportedQ3 2023
XTNTXtant Medical Holdings, Inc.$38.2M1.40%48.83%Not reportedQ3 2023
GOGOGogo Inc.$35.7M1.31%6.57%+30.8%Q3 2024
AMRXAmneal Pharmaceuticals, Inc.$35.4M1.30%0.90%+16.2%Q1 2023
AVRAnteris Technologies Global Corp.$30.7M1.13%5.69%+118.5%Q4 2024
ETONEton Pharmaceuticals, Inc.$29M1.07%4.30%Not reportedQ2 2024
EOLSEvolus, Inc.$26.2M0.96%9.69%+9.6%Q3 2023
TNGXTango Therapeutics, Inc.$26.2M0.96%0.87%-65.0%Q3 2021
LBRXLB Pharmaceuticals Inc$26M0.96%3.67%+56.0%Q3 2025
FOXFFox Factory Holding Corp$24.5M0.90%3.56%-32.0%Q4 2024
MLYSMineralys Therapeutics, Inc.$24.3M0.89%1.09%+690.5%Q1 2024
ZVRAZevra Therapeutics, Inc.$23.5M0.87%4.27%+42.3%Q3 2023
FULCFulcrum Therapeutics, Inc.$23.4M0.86%4.58%-29.0%Q4 2022
FOSLFossil Group, Inc.$23.3M0.86%9.26%+6.7%Q2 2023
RDNWRideNow Group, Inc.$23.1M0.85%149.33%Not reportedQ2 2022
ABEOAbeona Therapeutics Inc.$22.5M0.83%8.82%+1.0%Q4 2022
CWHCamping World Holdings, Inc.$22.3M0.82%Not reported+207.9%Q4 2025
ADCTADC Therapeutics SA$21M0.77%4.40%+2.2%Q4 2022
TITNTitan Machinery Inc.$21M0.77%5.37%+2.8%Q3 2024
HLFHerbalife Ltd.$19.9M0.73%1.31%+53.5%Q1 2025
IMAXImax Corp$19.6M0.72%0.94%+8.1%Q4 2020
VSTMVerastem, Inc.$19M0.70%4.08%+675.7%Q2 2024
BCRXBiocryst Pharmaceuticals Inc$18.9M0.70%0.78%+46.5%Q4 2025
AVTXAvalo Therapeutics, Inc.$18.4M0.68%5.01%Not reportedQ3 2021
RMRRMR Group Inc.$17.8M0.65%7.65%Not reportedQ4 2020
RYAMRayonier Advanced Materials Inc.$17.7M0.65%2.37%-11.1%Q1 2016
GERNGeron Corp$16.7M0.62%1.75%+24.4%Q3 2025
BNTCBenitec Biopharma Inc.$15.3M0.56%4.19%+38.5%Q2 2024
ABVXAbivax S.A.$15.3M0.56%0.17%-10.4%Q4 2023
ITGRInteger Holdings Corp$15.1M0.56%0.50%+68.6%Q4 2025
KROSKeros Therapeutics, Inc.$15M0.55%6.89%+277.5%Q2 2020
JACKJack in the Box Inc$14.9M0.55%8.10%+78.1%Q2 2025
JCAPJefferson Capital, Inc. / DE$14.4M0.53%1.35%+25.0%Q2 2025
AURAAura Biosciences, Inc.$14.2M0.52%3.30%Not reportedQ4 2021
USNAUsana Health Sciences Inc$14.2M0.52%4.39%+38.5%Q4 2025
PCVXVaxcyte, Inc.$13.9M0.51%0.17%NewQ1 2026
MDXGMimedx Group, Inc.$13.4M0.49%2.28%+40.6%Q4 2022
ASRTAssertio Holdings, Inc.$13.2M0.49%10.74%+17.9%Q3 2023
DSGRDistribution Solutions Group, Inc.$13M0.48%1.07%+49.9%Q2 2025
AGMBAgomab Therapeutics NV$12.9M0.47%3.51%NewQ1 2026
HLXCHelix Acquisition Corp. III$12.7M0.47%Not reportedNewQ1 2026
APYXApyx Medical Corp$12.7M0.47%8.22%-13.4%Q4 2024
SLNSilence Therapeutics plc$11.3M0.42%1.51%+39.2%Q1 2024
JANXJanux Therapeutics, Inc.$11.3M0.41%1.33%NewQ1 2026
Q4 2025Reported Feb 13, 2026131 positions
TBBKBancorp, Inc.$72.4M2.39%2.53%+25.7%Q2 2014
ESTAEstablishment Labs Holdings Inc.$72M2.38%3.37%-50.0%Q3 2018
HGVHilton Grand Vacations Inc.$69.9M2.31%1.88%-6.4%Q4 2022
SLNOSoleno Therapeutics Inc$60.8M2.01%2.51%+52.1%Q4 2019
XTNTXtant Medical Holdings, Inc.$53.6M1.77%48.84%Not reportedQ3 2023
FULCFulcrum Therapeutics, Inc.$48.6M1.61%6.45%-8.1%Q4 2022
BVSBioventus Inc.$45M1.49%Not reported+4.1%Q3 2022
SVRASavara Inc$44.3M1.46%3.59%-16.3%Q3 2023
EOLSEvolus, Inc.$38.7M1.28%8.95%+1.6%Q3 2023
FOXFFox Factory Holding Corp$37.4M1.24%5.24%+200.3%Q4 2024
PTONPeloton Interactive, Inc.$36.5M1.21%Not reported+60.4%Q1 2020
GOGOGogo Inc.$31.7M1.05%5.05%Not reportedQ3 2024
TNGXTango Therapeutics, Inc.$31.7M1.05%2.63%+97.4%Q3 2021
AMRXAmneal Pharmaceuticals, Inc.$30.8M1.02%0.78%-42.1%Q1 2023
EBEventbrite, Inc.$30.5M1.01%6.83%+0.3%Q2 2024
ABEOAbeona Therapeutics Inc.$26.2M0.86%9.02%+8.7%Q4 2022
RAPTRAPT Therapeutics, Inc.$25.5M0.84%2.72%+21.0%Q4 2024
GUTSFractyl Health, Inc.$23.9M0.79%7.07%-10.6%Q3 2025
AVTXAvalo Therapeutics, Inc.$22.4M0.74%6.67%Not reportedQ3 2021
ABVXAbivax S.A.$20.7M0.68%0.20%-72.5%Q4 2023
ETONEton Pharmaceuticals, Inc.$19.9M0.66%4.35%Not reportedQ2 2024
GMEDGlobus Medical Inc$19.6M0.65%0.17%-25.0%Q3 2025
ADCTADC Therapeutics SA$19.3M0.64%4.35%+141.6%Q4 2022
FOSLFossil Group, Inc.$19M0.63%9.27%+35.4%Q2 2023
TITNTitan Machinery Inc.$18.4M0.61%5.22%+11.3%Q3 2024
RDNWRideNow Group, Inc.$18.1M0.60%149.33%Not reportedQ2 2022
IMAXImax Corp$17.6M0.58%0.88%-52.1%Q4 2020
RMRRMR Group Inc.$17.1M0.57%7.65%Not reportedQ4 2020
QUREuniQure N.V.$16.7M0.55%1.12%-30.6%Q4 2016
JACKJack in the Box Inc$16.4M0.54%4.58%+44.3%Q2 2025
MDXGMimedx Group, Inc.$16.4M0.54%1.63%+64.8%Q4 2022
CRMTAmericas Carmart Inc$16.3M0.54%7.77%Not reportedQ2 2016
ZVRAZevra Therapeutics, Inc.$15.9M0.52%3.12%-10.1%Q3 2023
DNTHDianthus Therapeutics, Inc.$15.5M0.51%0.87%Not reportedQ3 2023
LBRXLB Pharmaceuticals Inc$15M0.50%2.67%Not reportedQ3 2025
TLSITriSalus Life Sciences, Inc.$14.5M0.48%4.14%+1.5%Q2 2025
ATXSAstria Therapeutics, Inc.$14M0.46%1.87%Not reportedQ2 2024
BNTCBenitec Biopharma Inc.$14M0.46%3.03%+23.9%Q2 2024
APYXApyx Medical Corp$13.9M0.46%9.51%+19.1%Q4 2024
UPBUpstream Bio, Inc.$13.4M0.44%0.91%-16.8%Q4 2024
JCAPJefferson Capital, Inc. / DE$13.4M0.44%1.03%Not reportedQ2 2025
FLWS1 800 Flowers Com Inc$13.3M0.44%Not reported+0.2%Q3 2018
SVCService Properties Trust$13M0.43%21.00%Not reportedQ4 2024
AVRAnteris Technologies Global Corp.$12.6M0.42%6.09%+31.9%Q4 2024
GERNGeron Corp$11.9M0.39%1.41%Not reportedQ3 2025
AURAAura Biosciences, Inc.$11.5M0.38%3.33%Not reportedQ4 2021
USNAUsana Health Sciences Inc$11.5M0.38%3.20%NewQ4 2025
HLFHerbalife Ltd.$11.4M0.38%0.85%-6.4%Q1 2025
RYAMRayonier Advanced Materials Inc.$10.6M0.35%2.69%+252.6%Q1 2016
BCRXBiocryst Pharmaceuticals Inc$10.6M0.35%0.64%NewQ4 2025
Q3 2025Reported Nov 14, 2025131 positions
ESTAEstablishment Labs Holdings Inc.$80.9M2.81%6.79%+11.2%Q3 2018
HGVHilton Grand Vacations Inc.$69.7M2.42%1.93%-16.2%Q4 2022
TBBKBancorp, Inc.$63.8M2.22%1.91%-12.0%Q2 2014
QUREuniQure N.V.$58.8M2.04%1.62%-50.9%Q4 2016
SLNOSoleno Therapeutics Inc$58.4M2.03%1.61%-13.7%Q4 2019
ABVXAbivax S.A.$47.3M1.64%0.88%-62.4%Q4 2023
XTNTXtant Medical Holdings, Inc.$44.4M1.54%48.85%Not reportedQ3 2023
FULCFulcrum Therapeutics, Inc.$43M1.49%8.63%+8.9%Q4 2022
AMRXAmneal Pharmaceuticals, Inc.$42.3M1.47%1.35%-3.3%Q1 2023
BVSBioventus Inc.$38.9M1.35%Not reported+10.0%Q3 2022
EOLSEvolus, Inc.$35.2M1.22%8.84%+36.4%Q3 2023
PTONPeloton Interactive, Inc.$33.3M1.16%Not reported+13.2%Q1 2020
IMAXImax Corp$32.6M1.13%1.85%-12.2%Q4 2020
SVRASavara Inc$31.3M1.09%5.08%+5.4%Q3 2023
ETONEton Pharmaceuticals, Inc.$25.6M0.89%4.39%Not reportedQ2 2024
ABEOAbeona Therapeutics Inc.$24.1M0.84%8.71%+4.5%Q4 2022
NKTRNektar Therapeutics$23.8M0.83%2.13%-41.0%Q1 2024
COGTCogent Biosciences, Inc.$21.6M0.75%1.08%-9.0%Q2 2023
KROSKeros Therapeutics, Inc.$19.5M0.68%3.04%-23.9%Q2 2020
GUTSFractyl Health, Inc.$19.3M0.67%9.18%NewQ3 2025
SVCService Properties Trust$19.1M0.66%4.20%-12.4%Q4 2024
IRONDisc Medicine, Inc.$19M0.66%0.82%Not reportedQ4 2022
CRMTAmericas Carmart Inc$18.8M0.65%7.79%Not reportedQ2 2016
ZVRAZevra Therapeutics, Inc.$18.8M0.65%3.51%+34.0%Q3 2023
TITNTitan Machinery Inc.$18.4M0.64%4.69%-3.5%Q3 2024
RMRRMR Group Inc.$18.1M0.63%7.65%Not reportedQ4 2020
FOXFFox Factory Holding Corp$17.7M0.61%1.74%Not reportedQ4 2024
EBEventbrite, Inc.$17.2M0.60%7.07%+7.1%Q2 2024
GMEDGlobus Medical Inc$17.2M0.60%0.22%NewQ3 2025
RAPTRAPT Therapeutics, Inc.$16.1M0.56%3.77%-34.5%Q4 2024
AVTXAvalo Therapeutics, Inc.$15.7M0.55%6.93%+24.1%Q3 2021
PVLAPalvella Therapeutics, Inc.$15.7M0.54%2.26%Not reportedQ4 2024
FLWS1 800 Flowers Com Inc$15.5M0.54%Not reported+68.4%Q3 2018
TNGXTango Therapeutics, Inc.$15.2M0.53%1.62%-47.4%Q3 2021
DNTHDianthus Therapeutics, Inc.$14.8M0.51%0.88%Not reportedQ3 2023
RDNWRideNow Group, Inc.$14.4M0.50%149.33%Not reportedQ2 2022
AURAAura Biosciences, Inc.$13.1M0.45%3.36%Not reportedQ4 2021
XNCRXencor Inc$12.9M0.45%1.54%+34.1%Q1 2025
AMLXAmylyx Pharmaceuticals, Inc.$12.7M0.44%0.85%-68.1%Q2 2023
GERNGeron Corp$12.4M0.43%1.41%NewQ3 2025
JACKJack in the Box Inc$11.9M0.41%0.72%Not reportedQ2 2025
BNTCBenitec Biopharma Inc.$11.8M0.41%3.19%Not reportedQ2 2024
VSTMVerastem, Inc.$11.4M0.40%1.94%-56.2%Q2 2024
UPBUpstream Bio, Inc.$11.2M0.39%1.10%Not reportedQ4 2024
LBRXLB Pharmaceuticals Inc$10.7M0.37%2.67%NewQ3 2025
SLDBSolid Biosciences Inc.$10.5M0.36%2.18%-0.2%Q1 2025
JCAPJefferson Capital, Inc. / DE$10.4M0.36%1.03%Not reportedQ2 2025
GPCRStructure Therapeutics Inc.$10.3M0.36%0.20%+118.7%Q1 2023
MDXGMimedx Group, Inc.$10.2M0.36%0.99%Not reportedQ4 2022
CMPSCOMPASS Pathways plc$9.91M0.34%1.80%-58.6%Q3 2024
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.